Literature DB >> 29143731

The Treatment of Depression in Primary Care.

Sebastian Trautmann1, Katja Beesdo-Baum.   

Abstract

BACKGROUND: General practitioners play a key role in the care of patients with depressive disorders. We studied the frequency and type of treatment of depressive disorders in primary care.
METHODS: In a cross-sectional epidemiological study on a particular day in six different regions in Germany, 253 physicians and 3563 unselected patients were asked to fill in a questionnaire assessing the diagnosis and treatment of depression. A total of 3431 usable patient data sets and 3211 sets of usable data from both the patient and the physician were subjected to further analysis.
RESULTS: 68.0% of the 490 patients in primary care who were classified as depressed according to the Depression Screening Questionnaire received treatment from their general practitioner or in other care settings; the probability of being treated by the general practitioner was higher for patients whose diagnosis was recognized by the general practitioner (92.8%) than for the remaining depressed patients (47.8%). On the day of data recording, 54.1% of the depressed patients were under treatment by the general practitioner and 21.2% had been referred to specialized treatment. Approximately 60% of the depressed patients were not being treated, as recommended in the guidelines, with antidepressant drugs, psychotherapy, or both. The likelihood of being treated in conformity with the guidelines depended on whether or not the general practitioner had made the diagnosis of depression (odds ratio [OR] = 7.5; 95% confidence interval = [4.9; 11.6]; p <0,001); it was also higher if the general practitioner had an additional qualification in psychotherapy (OR = 1.9; [1.1; 3.4]; p = 0.022).
CONCLUSION: The finding that a relevant proportion of patients with depressive disorders in primary care are inadequately treated indicates the need to improve general practitioners' ability to diagnose these conditions and determine the indication for treatment.

Entities:  

Mesh:

Year:  2017        PMID: 29143731      PMCID: PMC5696564          DOI: 10.3238/arztebl.2017.0721

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  23 in total

1.  The impact of psychosomatic co-morbidity on discordance with respect to reasons for encounter in general practice.

Authors:  Antonius Schneider; Eva Wartner; Isabelle Schumann; Elisabeth Hörlein; Peter Henningsen; Klaus Linde
Journal:  J Psychosom Res       Date:  2012-10-02       Impact factor: 3.006

2.  Who receives depression-specific treatment? A secondary data-based analysis of outpatient care received by over 780,000 statutory health-insured individuals diagnosed with depression.

Authors:  Stefanie Boenisch; Rueya-Daniela Kocalevent; Herbert Matschinger; Roland Mergl; Claudia Wimmer-Brunauer; Martin Tauscher; Dietmar Kramer; Ulrich Hegerl; Anke Bramesfeld
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-02-25       Impact factor: 4.328

3.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

4.  Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition.

Authors:  Roland Mergl; Isabel Seidscheck; Antje-Kathrin Allgaier; Hans-Jürgen Möller; Ulrich Hegerl; Verena Henkel
Journal:  Depress Anxiety       Date:  2007       Impact factor: 6.505

5.  Improving quality of care for depression: the German Action Programme for the implementation of evidence-based guidelines.

Authors:  Martin Härter; Isaac Bermejo; Günter Ollenschläger; Frank Schneider; Wolfgang Gaebel; Ulrich Hegerl; Wilhelm Niebling; Mathias Berger
Journal:  Int J Qual Health Care       Date:  2005-10-31       Impact factor: 2.038

6.  Recognition, management, and course of anxiety and depression in general practice.

Authors:  J Ormel; M W Koeter; W van den Brink; G van de Willige
Journal:  Arch Gen Psychiatry       Date:  1991-08

7.  Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI).

Authors:  H U Wittchen; G Lachner; U Wunderlich; H Pfister
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-11       Impact factor: 4.328

8.  Major depression treatment in Germany-descriptive analysis of health insurance fund routine data and assessment of guideline-adherence.

Authors:  Hauke Felix Wiegand; Christoph Sievers; Matthias Schillinger; Frank Godemann
Journal:  J Affect Disord       Date:  2015-10-05       Impact factor: 4.839

Review 9.  Observational studies of depression in primary care: what do we know?

Authors:  Gail Gilchrist; Jane Gunn
Journal:  BMC Fam Pract       Date:  2007-05-11       Impact factor: 2.497

10.  Alcohol dependence and treatment utilization in Europe - a representative cross-sectional study in primary care.

Authors:  Jürgen Rehm; Allaman Allamani; Zsuzsanna Elekes; Andrzej Jakubczyk; Jakob Manthey; Charlotte Probst; Pierluigi Struzzo; Roberto Della Vedova; Antoni Gual; Marcin Wojnar
Journal:  BMC Fam Pract       Date:  2015-07-29       Impact factor: 2.497

View more
  19 in total

1.  Coordinated Treatment of Depression in Elderly People in Primary Care.

Authors:  Lars P Hölzel; Frederike Bjerregaard; Christiane Bleich; Sigrid Boczor; Martin Härter; Hans-Helmut König; Thomas Kloppe; Wilhelm Niebling; Martin Scherer; Iris Tinsel; Michael Hüll
Journal:  Dtsch Arztebl Int       Date:  2018-11-02       Impact factor: 5.594

2.  In Reply.

Authors:  Katja Beesdo-Baum
Journal:  Dtsch Arztebl Int       Date:  2018-02-23       Impact factor: 5.594

3.  Limitations of the Study.

Authors:  Heinz-Harald Abholz Emeritus; Günther Egidi; Michael M Kochen; Uwe Popert
Journal:  Dtsch Arztebl Int       Date:  2018-02-23       Impact factor: 5.594

4.  Incomplete and Curtailed Statements.

Authors:  Armin Mainz
Journal:  Dtsch Arztebl Int       Date:  2018-02-23       Impact factor: 5.594

5.  Challenges in the Transition from In-Patient to Out-Patient Treatment in Depression.

Authors:  Hauke Felix Wiegand; Joachim Saam; Ursula Marschall; Andrea Chmitorz; Levente Kriston; Mathias Berger; Klaus Lieb; Lars P Hölzel
Journal:  Dtsch Arztebl Int       Date:  2020-07-06       Impact factor: 5.594

Review 6.  [Psychotherapy of depressive disorders : Procedures, evidence and perspectives].

Authors:  R Meister; A Jansen; M Berger; H Baumeister; T Bschor; T Harfst; M Hautzinger; L Kriston; C Kühner; H Schauenburg; S G Schorr; F Schneider; M Härter
Journal:  Nervenarzt       Date:  2018-03       Impact factor: 1.214

7.  A retrospective examination of care pathways in individuals with treatment-resistant depression.

Authors:  Elana Day; Rupal Shah; Rachael W Taylor; Lindsey Marwood; Kimberley Nortey; Jade Harvey; R Hamish McAllister-Williams; John R Geddes; Alvaro Barrera; Allan H Young; Anthony J Cleare; Rebecca Strawbridge
Journal:  BJPsych Open       Date:  2021-05-14

8.  Perceived need for treatment and non-utilization of outpatient psychotherapy in old age: two cohorts of a nationwide survey.

Authors:  Paul Gellert; Sonia Lech; Eva-Marie Kessler; Wolfram Herrmann; Susanne Döpfmer; Klaus Balke; Monika Oedekoven; Adelheid Kuhlmey; Susanne Schnitzer
Journal:  BMC Health Serv Res       Date:  2021-05-10       Impact factor: 2.655

9.  Antidepressant prescription practice and related factors in Switzerland: a cross-sectional analysis of health claims data.

Authors:  Elisa Haller; Birgit Watzke; Eva Blozik; Thomas Rosemann; Oliver Reich; Carola A Huber; Markus Wolf
Journal:  BMC Psychiatry       Date:  2019-06-24       Impact factor: 3.630

10.  Primary care professionals' attitudes towards digital health interventions for common mental disorders: study protocol for a mixed methods systematic review.

Authors:  Maria Hanf; Julian Hirt; Marjan van den Akker
Journal:  BMJ Open       Date:  2021-06-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.